Kodiak Sciences Inc
Kodiak Sciences Inc (KOD) Wheel Strategy
KOD wheel strategy scan found 10 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 228.1%.
Read more
Running a KOD wheel strategy lets you generate consistent premium income on Kodiak Sciences Inc while setting your own entry and exit prices on the underlying. Kodiak Sciences Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own KOD, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best KOD wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on KOD, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable KOD wheel from a losing one.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD.
The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the KOD wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your KOD wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 16, 2026 | 26.00 | $3.90 | $4.55 | -0.25 | 28 | 100% | 52.0% | 228.1% | 5 |
| Oct 16, 2026 | 24.00 | $3.30 | $3.80 | -0.21 | 28 | 100% | 57.0% | 206.4% | 1 |
| Oct 16, 2026 | 22.00 | $2.40 | $3.35 | -0.18 | 28 | 100% | 62.3% | 198.5% | 11 |
| Oct 16, 2026 | 25.00 | $3.40 | $3.75 | -0.23 | 28 | 100% | 54.4% | 195.5% | 463 |
| Oct 16, 2026 | 23.00 | $1.80 | $3.00 | -0.19 | 28 | 100% | 59.6% | 170.0% | 13 |
| Oct 16, 2026 | 20.00 | $1.55 | $2.33 | -0.14 | 28 | 100% | 67.8% | 151.5% | 66 |
| Dec 18, 2026 | 16.00 | $2.00 | $3.10 | -0.11 | 91 | 100% | 52.0% | 77.7% | 0 |
| Oct 16, 2026 | 15.00 | $0.50 | $0.65 | -0.06 | 28 | 100% | 82.0% | 56.5% | 7,045 |
| Dec 18, 2026 | 15.00 | $1.70 | $2.03 | -0.09 | 91 | 100% | 54.2% | 54.1% | 6 |
| Dec 18, 2026 | 14.00 | $0.50 | $1.18 | -0.07 | 91 | 100% | 56.6% | 33.7% | 52 |
As of September 22, 2026
Run the Wheel on KOD With Confidence
Find the best KOD wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→